- Home
- NBTX vs ISTR Comparison
NBTX vs ISTR Comparison
Compare NBTX & ISTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- ISTR
- Stock Information
- Founded
- NBTX 2003
- ISTR 2006
- Country
- NBTX France
- ISTR United States
- Employees
- NBTX N/A
- ISTR N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- ISTR Major Banks
- Sector
- NBTX Health Care
- ISTR Finance
- Exchange
- NBTX Nasdaq
- ISTR Nasdaq
- Market Cap
- NBTX 201.9M
- ISTR 206.6M
- IPO Year
- NBTX 2020
- ISTR 2014
- Fundamental
- Price
- NBTX $4.00
- ISTR $23.65
- Analyst Decision
- NBTX Strong Buy
- ISTR
- Analyst Count
- NBTX 2
- ISTR 0
- Target Price
- NBTX $11.50
- ISTR N/A
- AVG Volume (30 Days)
- NBTX 6.4K
- ISTR 38.1K
- Earning Date
- NBTX 11-19-2024
- ISTR 10-21-2024
- Dividend Yield
- NBTX N/A
- ISTR 1.77%
- EPS Growth
- NBTX N/A
- ISTR N/A
- EPS
- NBTX N/A
- ISTR 1.79
- Revenue
- NBTX $45,220,186.00
- ISTR $82,729,000.00
- Revenue This Year
- NBTX N/A
- ISTR N/A
- Revenue Next Year
- NBTX N/A
- ISTR $12.80
- P/E Ratio
- NBTX N/A
- ISTR $12.93
- Revenue Growth
- NBTX 526.17
- ISTR N/A
- 52 Week Low
- NBTX $4.04
- ISTR $9.83
- 52 Week High
- NBTX $8.96
- ISTR $24.00
- Technical
- Relative Strength Index (RSI)
- NBTX 37.42
- ISTR 72.64
- Support Level
- NBTX $4.07
- ISTR $20.63
- Resistance Level
- NBTX $4.44
- ISTR $24.00
- Average True Range (ATR)
- NBTX 0.21
- ISTR 0.61
- MACD
- NBTX -0.03
- ISTR 0.25
- Stochastic Oscillator
- NBTX 0.00
- ISTR 94.87
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About ISTR Investar Holding Corporation
Investar Holding Corp is a us-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.